[1] Hegedüs L.  Clinical practice. The thyroid nodule[J]. N Engl J Med, 2004, 351(17): 1764-1771.   doi: 10.1056/NEJMcp031436
[2] Cesareo R, Naciu AM, Iozzino M, et al.  Nodule size as predictive factor of efficacy of radiofrequency ablation in treating autonomously functioning thyroid nodules[J]. Int J Hyperthermia, 2018, 34(5): 617-623.   doi: 10.1080/02656736.2018.1430868
[3] Cervelli R, Mazzeo S, Boni G, et al.  Comparison between radioiodine therapy and single-session radiofrequency ablation of autonomously functioning thyroid nodules: a retrospective study[J]. Clin Endocrinol (Oxf), 2019, 90(4): 608-616.   doi: 10.1111/cen.13938
[4]

Salih AM, Kakamad FH, Nihad H. Hyperfunctioning papillary thyroid carcinoma: a case report with lite, rature review[J/OL]. Int J Surg Case Rep, 2016, 26: 202–204[2019-10-07]. https://linkinghub.elsevier.com/retrieve/pii/S2210-2612(16)30293-0. DOI: 10.1016/j.ijscr.2016.08.001.
[5] Neuman D, Kuker R, Vendrame F.  Marine-Lenhart syndrome: case report, diagnosis, and management[J]. Case Rep Endocrinol, 2018, 2018: 3268010-.   doi: 10.1155/2018/3268010
[6] Dunkelmann S, Wolf R, Koch A, et al.  Incidence of radiation-induced Graves′ disease in patients treated with radioiodine for thyroid autonomy before and after introduction of a high-sensitivity TSH receptor antibody assay[J]. Eur J Nucl Med Mol Imaging, 2004, 31(10): 1428-1434.   doi: 10.1007/s00259-004-1519-8
[7] Giovanella L, D'Aurizio F, Campenni' A, et al.  Searching for the most effective thyrotropin (TSH) threshold to rule-out autonomously functioning thyroid nodules in iodine deficient regions[J]. Endocrine, 2016, 54(3): 757-761.   doi: 10.1007/s12020-016-1094-3
[8] Celano M, Sponziello M, Tallini G, et al.  Increased expression of pro-angiogenic factors and vascularization in thyroid hyperfunctioning adenomas with and without TSH receptor activating mutations[J]. Endocrine, 2013, 43(1): 147-153.   doi: 10.1007/s12020-012-9747-3
[9] Andrade BM, Araujo RL, Perry RL, et al.  A novel role for AMP-kinase in the regulation of the Na+/I- -symporter and iodide uptake in the rat thyroid gland[J]. Am J Physiol Cell Physiol, 2011, 300(6): C1291-C1297.   doi: 10.1152/ajpcell.00136.2010
[10] Floor SL, Trésallet C, Hébrant A, et al.  microRNA expression in autonomous thyroid adenomas: correlation with mRNA regulation[J]. Mol Cell Endocrinol, 2015, 411: 1-10.   doi: 10.1016/j.mce.2015.04.001
[11] Gharib H, Tuttle RM, Baskin HJ, et al.  Subclinical thyroid dysfunction: a joint statement on management from the American association of clinical endocrinologists, the American thyroid association, and the endocrine society[J]. J Clin Endocrinol Metab, 2005, 90(1): 581-585.   doi: 10.1210/jc.2004-1231
[12] Haugen BR, Alexander EK, Bible KC, et al.  2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer[J]. Thyroid, 2016, 26(1): 1-133.   doi: 10.1089/thy.2015.0020
[13] 马春旭, 袁卫红.  甲状腺结节影像学诊断研究进展[J]. 国际放射医学核医学杂志, 2014, 38(1): 48-52, 63.   doi: 10.3760/cma.j.issn.1673-4114.2014.01.010
Ma CX, Yuan WH.  Advanced research on imaging diagnosis of thyroid nodule[J]. Int J Radiat Med Nucl Med, 2014, 38(1): 48-52, 63.   doi: 10.3760/cma.j.issn.1673-4114.2014.01.010
[14] Verburg FA, Aktolun C, Chiti A, et al.  Why the European association of nuclear medicine has declined to endorse the 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer[J]. Eur J Nucl Med Mol Imaging, 2016, 43(6): 1001-1005.   doi: 10.1007/s00259-016-3327-3
[15] Gharib H, Papini E, Paschke R, et al.  American association of clinical endocrinologists, associazione medici endocrinologi, and European thyroid association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules[J]. Endocr Pract, 2010, 16(Suppl 1): S1-43.   doi: 10.4158/10024.GL
[16]

Moreno-Reyes R, Kyrilli A, Lytrivi M, et al. Is there still a role for thyroid scintigraphy in the workup of a thyroid nodule in the era of fine needle aspiration cytology and molecular testing?[J/OL]. F1000Res, 2016, 5: 763[2019-10-07]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4850874. DOI: 10.12688/f1000research.7880.1.
[17] Corvilain B.  The natural history of thyroid autonomy and hot nodules[J]. Ann Endocrinol (Paris), 2003, 64(1): 17-22.   doi: AE-02-2003-64-1-0003-4266-101019-ART06
[18] Bahn RS, Burch HB, Cooper DS, et al.  Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American thyroid association and American association of clinical endocrinologists[J]. Endocr Pract, 2011, 17(3): 456-520.   doi: 10.4158/ep.17.3.456
[19] Landerholm K, Wasner AM, Järhult J.  Incidence and risk factors for injuries to the recurrent laryngeal nerve during neck surgery in the moderate-volume setting[J]. Langenbecks Arch Surg, 2014, 399(4): 509-515.   doi: 10.1007/s00423-013-1154-6
[20] Pacella CM.  Image-guided thermal ablation of benign thyroid nodules[J]. J Ultrasound, 2017, 20(4): 347-349.   doi: 10.1007/s40477-017-0269-y
[21] Korevaar TI.  Evidence-based tightrope walking: the 2017 guidelines of the American thyroid association for the diagnosis and management of thyroid disease during pregnancy and the postpartum[J]. Thyroid, 2017, 27(3): 309-311.   doi: 10.1089/thy.2017.29040.tko
[22] Collet TH, Gussekloo J, Bauer DC, et al.  Subclinical hyperthyroidism and the risk of coronary heart disease and mortality[J]. Arch Intern Med, 2012, 172(10): 799-809.   doi: 10.1001/archinternmed.2012.402
[23] Rudzki GM, Lenart-Lipińska M, Smoleń A, et al.  Subclinical hyperthyroidism in the course of autonomous nodules-clinical evaluation[J]. Endokrynol Pol, 2019, 70(2): 157-164.   doi: 10.5603/EP.a2018.0088
[24] Jung SL, Baek JH, Lee JH, et al.  Efficacy and safety of radiofrequency ablation for benign thyroid nodules: a prospective multicenter study[J]. Korean J Radiol, 2018, 19(1): 167-174.   doi: 10.3348/kjr.2018.19.1.167
[25] Døssing H, Bennedbaek FN, Hegedüs L.  Effect of ultrasound-guided interstitial laser photocoagulation on benign solitary solid cold thyroid nodules-a randomised study[J]. Eur J Endocrinol, 2005, 152(3): 341-345.   doi: 10.1530/eje.1.01865
[26] Papini E, Pacella CM, Solbiati LA, et al.  Minimally-invasive treatments for benign thyroid nodules: a Delphi-based consensus statement from the Italian minimally-invasive treatments of the thyroid (MITT) group[J]. Int J Hyperthermia, 2019, 36(1): 376-382.   doi: 10.1080/02656736.2019.1575482
[27] Sung JY, Baek JH, Jung SL, et al.  Radiofrequency ablation for autonomously functioning thyroid nodules: a multicenter study[J]. Thyroid, 2015, 25(1): 112-117.   doi: 10.1089/thy.2014.0100
[28] Bernardi S, Stacul F, Michelli A, et al.  12-month efficacy of a single radiofrequency ablation on autonomously functioning thyroid nodules[J]. Endocrine, 2017, 57(3): 402-408.   doi: 10.1007/s12020-016-1174-4
[29] Døssing H, Bennedbaek FN, Bonnema SJ, et al.  Randomized prospective study comparing a single radioiodine dose and a single laser therapy session in autonomously functioning thyroid nodules[J]. Eur J Endocrinol, 2007, 157(1): 95-100.   doi: 10.1530/EJE-07-0094
[30] Pacella CM, Mauri G.  Is there a role for minimally invasive thermal ablations in the treatment of autonomously functioning thyroid nodules?[J]. Int J Hyperthermia, 2018, 34(5): 636-638.   doi: 10.1080/02656736.2018.1462537
[31] Gharib H, Papini E, Garber JR, et al.  American association of clinical endocrinologists, American college of endocrinology, and associazione medici endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules-2016 update[J]. Endocr Pract, 2016, 22(5): 622-639.   doi: 10.4158/ep161208.GL
[32] Azevedo MF, Casulari LA.  Hyperfunctioning thyroid cancer: a five-year follow-up[J]. Arq Bras Endocrinol Metabol, 2010, 54(1): 78-80.   doi: 10.1590/S0004-27302010000100013
[33] Bozbıyık O, Öztürk Ş, Ünver M, et al.  Reliability of fine needle aspiration biopsy in large thyroid nodules[J]. Turk J Surg, 2017, 33(1): 10-13.   doi: 10.5152/UCD.2017.3329
[34] Godazandeh G, Kashi Z, Zargarnataj S, et al.  Evaluation the relationship between thyroid nodule size with malignancy and accuracy of fine needle aspiration biopsy (FNAB)[J]. Acta Inform. Med, 2016, 24(5): 347-350.   doi: 10.5455/aim.2016.24.347-350
[35]

Lima MJ, Soares V, Koch P, et al. Autonomously hyperfunctioning cystic nodule harbouring thyroid carcinoma-case report and literature review[J/OL]. Int J Surg Case Rep, 2018, 42: 287−289[2019-10-07]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767900. DOI: 10.1016/j.ijscr.2018.01.002.
[36] 牛娜, 林岩松, 陈永辉, 等.  Marine-Lenhart综合征一例[J]. 中华内分泌代谢杂志, 2010, 26(6): 521-522.   doi: 10.3760/cma.j.issn.1000-6699.2010.06.027
Niu N, Lin YS, Chen YH, et a1.  Marine-Lenhart syndrome: one case report[J]. Chin J Endocrinol Metab, 2010, 26(6): 521-522.   doi: 10.3760/cma.j.issn.1000-6699.2010.06.027
[37] 曾芳芳, 刘红, 周丽诺, 等.  非典型Marine-Lenhart综合征2例报道并文献复习[J]. 国际内分泌代谢杂志, 2017, 37(1): 65-67.   doi: 10.3760/cma.j.issn.1673-4157.2017.01.19
Zeng FF, Liu H, Zhou LN, et al.  Atypical Marine-Lenhart syndrome: two cases report and literatures review[J]. Int J Endocrinol Metab, 2017, 37(1): 65-67.   doi: 10.3760/cma.j.issn.1673-4157.2017.01.19
[38] 刘娜, 刘雪辉.  131I治疗甲状腺自主高功能腺瘤诱发格雷夫斯病一例[J]. 中华核医学与分子影像杂志, 2019, 39(9): 548-549.   doi: 10.3760/cma.j.issn.2095-2848.2019.09.010
Liu N, Liu XH.  Graves disease after 131I therapy for autonomously functioning thyroid adenoma: case report[J]. Chin J Nucl Mol Imaging, 2019, 39(9): 548-549.   doi: 10.3760/cma.j.issn.2095-2848.2019.09.010